US Patent Issued to GENETHON, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE D'EVRY VAL D'ESSONNE, SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ASSOCIATION INSTITUT DE MYOLOGIE on May 20 for "Acid-alpha glucosidase variants and uses thereof" (American, French Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,305,187, issued on May 20, was assigned to GENETHON (Evry, France), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), UNIVERSITE D'EVRY VAL D'ESSONNE (Evry-Courcouronnes, France), SORBONNE UNIVERSITE (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris) and ASSOCIATION INSTITUT DE MYOLOGIE (Paris).

"Acid-alpha glucosidase variants and uses thereof" was invented by Federico Mingozzi (Philadelphia) and Giuseppe Ronzitti (Fontainebleau, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to variants of acid-alpha glucosidase and uses thereof."

The patent was filed on April 25, 2022, under A...